{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T08:56:42Z","timestamp":1789376202982,"version":"build-2803163510"},"reference-count":18,"publisher":"Cambridge University Press (CUP)","issue":"4","license":[{"start":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T00:00:00Z","timestamp":1442534400000},"content-version":"unspecified","delay-in-days":12009,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can. j. neurol. sci."],"published-print":{"date-parts":[[1982,11]]},"abstract":"<jats:title>SUMMARY:<\/jats:title><jats:p>Although several cases of acute hepatic failure associated with the administration of valproic acid (VPA) have been reported, the pathogenesis of this problem remains unclear. We report the case of a 40 month old male with a chronic seizure disorder treated with VPA and phenytoin for two years, who developed sudden progressive neurological deterioration with evidence of increased intracranial pressure and hepatic failure. The clinical features closely resembled those of Reye\u2019s syndrome suggesting the possibility of a common pathogenesis.<\/jats:p>","DOI":"10.1017\/s0317167100044358","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T07:34:47Z","timestamp":1469691287000},"page":"435-437","source":"Crossref","is-referenced-by-count":7,"title":["Valproic Acid Producing a Reye-Like Syndrome"],"prefix":"10.1017","volume":"9","author":[{"given":"D. L.","family":"Keene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Humphreys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.P.","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2015,9,18]]},"reference":[{"key":"S0317167100044358_ref240","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410070423"},{"key":"S0317167100044358_ref239","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.28.9.961"},{"key":"S0317167100044358_ref238","first-page":"1110","article-title":"Acute Liver Disease Associated with Sodium Valproate","volume":"7","author":"Ware","year":"1980","journal-title":"Ann. Neuro"},{"key":"S0317167100044358_ref237","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1979.02130030050008"},{"key":"S0317167100044358_ref235","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410070103"},{"key":"S0317167100044358_ref234","first-page":"242","article-title":"A Direct Hepatotoxic Effect of Valproic Acid","author":"Sussman","year":"1979","journal-title":"J.A.M.A"},{"key":"S0317167100044358_ref233","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197904263001706"},{"key":"S0317167100044358_ref230","unstructured":"Luther R. ; \u2013 Abbott Laboratories \u2013 personal communications."},{"key":"S0317167100044358_ref227","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(79)80110-9"},{"key":"S0317167100044358_ref226","first-page":"273","article-title":"Valproic Acid and Fatal Hepatitis","volume":"29","author":"Donat","year":"1979","journal-title":"Neurol"},{"key":"S0317167100044358_ref225","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.28.2.105"},{"key":"S0317167100044358_ref224","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1056\/NEJM198003203021204","article-title":"Drug Therapy \u2013 Valproic Acid","volume":"302","author":"Browne","year":"1980","journal-title":"N. Eng. J. Med"},{"key":"S0317167100044358_ref223","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.1980.tb04339.x"},{"key":"S0317167100044358_ref229","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(80)92861-5"},{"key":"S0317167100044358_ref236","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.25.3.296"},{"key":"S0317167100044358_ref228","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.31.11.1473"},{"key":"S0317167100044358_ref232","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.30.1.31"},{"key":"S0317167100044358_ref231","first-page":"603","article-title":"Changes of Hemostasis During Treatment with Sodium Dipropylacetate (Depakene)","volume":"24","author":"Monnet","year":"1979","journal-title":"Pediatrics"}],"container-title":["Canadian Journal of Neurological Sciences \/ Journal Canadien des Sciences Neurologiques"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0317167100044358","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T16:26:31Z","timestamp":1558715191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0317167100044358\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1982,11]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1982,11]]}},"alternative-id":["S0317167100044358"],"URL":"https:\/\/doi.org\/10.1017\/s0317167100044358","relation":{},"ISSN":["0317-1671","2057-0155"],"issn-type":[{"value":"0317-1671","type":"print"},{"value":"2057-0155","type":"electronic"}],"subject":[],"published":{"date-parts":[[1982,11]]}}}